In Silico Analysis of Conformational Changes Induced by Normal and Mutation of Macrophage Infectivity Potentiator Catalytic Residues and its Interactions with Rapamycin

[1]  J. Natarajan,et al.  Combination of site directed mutagenesis and secondary structure analysis predicts the amino acids essential for stability of M. leprae MurE , 2014, Interdisciplinary Sciences: Computational Life Sciences.

[2]  I. Adzhubei,et al.  Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2 , 2013, Current protocols in human genetics.

[3]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[4]  U. Holzgrabe,et al.  Pipecolic acid derivatives as small-molecule inhibitors of the Legionella MIP protein. , 2011, Journal of medicinal chemistry.

[5]  R. Vijayan,et al.  In silico Modeling of 1A-Adrenoceptor: Interaction of its Normal and Mutated Active Sites with Noradrenaline as well as its Agonist and Antagonist , 2007 .

[6]  M. Schroeder,et al.  LIGSITEcsc: predicting ligand binding sites using the Connolly surface and degree of conservation , 2006, BMC Structural Biology.

[7]  Arlo Z. Randall,et al.  Prediction of protein stability changes for single‐site mutations using support vector machines , 2005, Proteins.

[8]  Piero Fariselli,et al.  I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure , 2005, Nucleic Acids Res..

[9]  H. Ke,et al.  Structures of calcineurin and its complexes with immunophilins-immunosuppressants. , 2003, Biochemical and biophysical research communications.

[10]  Jie Liang,et al.  CASTp: Computed Atlas of Surface Topography of proteins , 2003, Nucleic Acids Res..

[11]  J. Heitman Faculty Opinions recommendation of Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes. , 2002 .

[12]  A. Sali,et al.  Comparative protein structure modeling of genes and genomes. , 2000, Annual review of biophysics and biomolecular structure.

[13]  G. Koehl,et al.  Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor , 2002, Nature Medicine.

[14]  J. Hacker,et al.  Crystal structure of Mip, a prolylisomerase from Legionella pneumophila , 2001, Nature Structural Biology.

[15]  P Willett,et al.  Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.

[16]  J. Hacker,et al.  Influence of site specifically altered Mip proteins on intracellular survival of Legionella pneumophila in eukaryotic cells , 1995, Infection and immunity.

[17]  D. Kamp,et al.  Infectivity of Legionella pneumophila mip mutant for alveolar epithelial cells , 1995, Current Microbiology.

[18]  J. Hacker,et al.  Studies on the uptake and intracellular replication of Legionella pneumophila in protozoa and in macrophage-like cells , 1994 .

[19]  J. Hacker,et al.  Characterization of Mip proteins of Legionella pneumophila. , 1994, FEMS microbiology letters.

[20]  J. Hacker,et al.  Mip protein of Legionella pneumophila exhibits peptidyl‐prolyl‐cis/trans isomerase (PPIase) activity , 1992, Molecular microbiology.

[21]  W. Winn,et al.  Legionnaires disease: historical perspective , 1988, Clinical Microbiology Reviews.

[22]  Rowbotham Tj,et al.  Current views on the relationships between amoebae, legionellae and man. , 1986 .

[23]  T. Rowbotham,et al.  Preliminary report on the pathogenicity of Legionella pneumophila for freshwater and soil amoebae. , 1980, Journal of clinical pathology.

[24]  W. Dowdle,et al.  Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. , 1977, The New England journal of medicine.

[25]  W. Delano The PyMOL Molecular Graphics System , 2002 .

[26]  M. Suthanthiran,et al.  Which way for drug-mediated immunosuppression? , 1994, Current opinion in immunology.

[27]  T. Rowbotham Current views on the relationships between amoebae, legionellae and man. , 1986, Israel journal of medical sciences.